Picotamide v aspirin for type 2 diabetes mellitus and peripheral arterial disease*
| Outcomes at 24 months | Picotamide | Aspirin | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Composite endpoint = death and non-fatal cardiovascular events. Other abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| All cause mortality | 2.8% | 5.1% | 45% (2 to 69) | 44 (22 to 1025) |
| Composite endpoint | 7.5% | 9.0% | 16% (–22 to 43) | Not significant |